Page 11 - SDIR5 Abstract book 21 12 2021.

Radiation-induced lymphocyte apoptosis as a possible biological predictor of radiotherapy toxicity
in prostate cancer patients ................................................................................................................. 18

Can miRNA expression patterns predict radiotoxicity in patients with glioblastoma? ...................... 19
Potential predictive role of K-ras gene mutation and BCL2 protein expression status in locally
advanced rectal cancers treated with neoadjuvant chemoradiotherapy .......................................... 20
Session: Imaging in cancer ................................................................................................................ 21

LECTURES ................................................................................................................................................ 21
Real-time microscopy of invasive cancer cells in the tumor microenvironment context .................. 21

Defining and imaging colon cancer heterogeneity ............................................................................. 22
Vessel co-option and resistance to therapy in glioblastoma .............................................................. 23
Short talks ............................................................................................................................................... 24

Characterizing the role of 4E-BP1 in breast cancer metastasis .......................................................... 24
Siramesine, a non-opioid σ2 receptor agonist as a potential agent for the development of novel
targeted treatments for pancreatic cancer ........................................................................................ 25

The Role of Nek2 on Centrosome Clustering in Cancer Cells with Extra Centrosomes ...................... 26
Sox2-targeted T cell therapy for treating multiple myeloma ............................................................. 27
POSTER SESSION .............................................................................................................................. 28

Pan-cancer analysis of the role of flap endonuclease 1 (FEN1) in human various tumors ................ 28
In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast
Cancer Cells ......................................................................................................................................... 29

Gene expression profiling of MSI and EMAST colorectal cancers ...................................................... 30
Expression and diagnostic potential of genes involved in PI3K/AKT/mTOR pathway in endometrial
cancer .................................................................................................................................................. 31
Intratumor heterogeneity of microsatellite instability in sporadic colorectal cancer ........................ 32

Multi-omic profiling of cancer cells, exosomes, and cell-free DNA isolated from the cerebrospinal
fluid of pediatric brain cancer patients ............................................................................................... 33

The effect of osteogenic differentiation on oral cancer stem cells’ miR-21 and miR-133 expression34
Evaluation of differential transcriptional regulator binding to alternative CD81 gene promoters .... 35

Methylation status of MGMT promoter in glioblastoma in Serbian patients: valuable marker or not?
............................................................................................................................................................ 36
The prognostic significance of interleukin-6 in hormonally dependent breast cancer ...................... 37
Role of TP53 and PTEN tumor suppressor genes alterations in breast cancer response to therapy . 38

A novel triple negative lipid rich breast cancer (TN/LRBC) patient derived xenograft (PDX) ............. 39
Quality of life in patients surgically treated for oral carcinoma ......................................................... 40

Genetic analysis of SMAD7 3′UTR in human colorectal cancer .......................................................... 41